{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:56:43Z","timestamp":1790665003804,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04580-6","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:04:23Z","timestamp":1790618663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Circulating Glypican 4 and mortality risk in patients with metastatic breast cancer\u2013results from the DESIREE study"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5582-4125","authenticated-orcid":false,"given":"Axel","family":"Muendlein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Brandtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Fasching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"van Mackelenbergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Thill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Heinzle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lelia","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"L\u00fcbbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherko","family":"K\u00fcmmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkmar","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark-Oliver","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Denkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Mundhenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivaramakrishna","family":"Rachakonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Nekljudova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e4rbel","family":"Felder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibylle","family":"Loibl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"4580_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/S00109-025-02520-5","volume":"103","author":"A Muendlein","year":"2025","unstructured":"Muendlein A, Leiherer A, Drexel H. Evaluation of circulating glypican 4 as a novel biomarker in disease - a comprehensive review. J Mol Med (Berl). 2025;103:355\u201364. https:\/\/doi.org\/10.1007\/S00109-025-02520-5.","journal-title":"J Mol Med (Berl)"},{"key":"4580_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2008-9-5-224","volume":"9","author":"J Filmus","year":"2008","unstructured":"Filmus J, Capurro M, Rast J. Glypicans. Genome Biol. 2008;9:224. https:\/\/doi.org\/10.1186\/gb-2008-9-5-224.","journal-title":"Genome Biol"},{"key":"4580_CR3","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.2337\/DB11-1395","volume":"61","author":"S Ussar","year":"2012","unstructured":"Ussar S, Bezy O, Bl\u00fcher M, Kahn CR. Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine. Diabetes. 2012;61:2289\u201398. https:\/\/doi.org\/10.2337\/DB11-1395.","journal-title":"Diabetes"},{"key":"4580_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40635-018-0216-z","volume":"7","author":"J Fisher","year":"2019","unstructured":"Fisher J, Linder A, Bentzer P. Elevated plasma glypicans are associated with organ failure in patients with infection. Intensive Care Med Exp. 2019;7:2. https:\/\/doi.org\/10.1186\/s40635-018-0216-z.","journal-title":"Intensive Care Med Exp"},{"key":"4580_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/J.ATHEROSCLEROSIS.2022.02.015","volume":"345","author":"A Muendlein","year":"2022","unstructured":"Muendlein A, Brandtner EM, Leiherer A, et al. Serum glypican-4 is a marker of future vascular risk and mortality in coronary angiography patients. Atherosclerosis. 2022;345:33\u20138. https:\/\/doi.org\/10.1016\/J.ATHEROSCLEROSIS.2022.02.015.","journal-title":"Atherosclerosis"},{"key":"4580_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/J.IJCARD.2022.08.018","volume":"369","author":"A Muendlein","year":"2022","unstructured":"Muendlein A, Heinzle C, Leiherer A, et al. Serum glypican-4 is associated with the 10-year clinical outcome of patients with peripheral artery disease. Int J Cardiol. 2022;369:54\u20139. https:\/\/doi.org\/10.1016\/J.IJCARD.2022.08.018.","journal-title":"Int J Cardiol"},{"key":"4580_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/J.CLINBIOCHEM.2023.110675","volume":"121","author":"A Muendlein","year":"2023","unstructured":"Muendlein A, Heinzle C, Leiherer A, et al. Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failure. Clin Biochem. 2023;121:110675. https:\/\/doi.org\/10.1016\/J.CLINBIOCHEM.2023.110675.","journal-title":"Clin Biochem"},{"key":"4580_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/FONC.2022.1045995","volume":"12","author":"A Muendlein","year":"2022","unstructured":"Muendlein A, Severgnini L, Decker T, et al. Circulating syndecan-1 and glypican-4 predict 12-month survival in metastatic colorectal cancer patients. Front Oncol. 2022;12:1045995. https:\/\/doi.org\/10.3389\/FONC.2022.1045995.","journal-title":"Front Oncol"},{"key":"4580_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000529547","volume":"46","author":"A Muendlein","year":"2023","unstructured":"Muendlein A, Heinzle C, Brandtner EM, et al. Circulating glypican-4 is a predictor of 24-month overall survival in metastatic breast cancer. Oncol Res Treat. 2023;46:151\u20136. https:\/\/doi.org\/10.1159\/000529547.","journal-title":"Oncol Res Treat"},{"key":"4580_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/J.ESMOOP.2022.100601","volume":"7","author":"M Schmidt","year":"2022","unstructured":"Schmidt M, L\u00fcbbe K, Decker T, et al. A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE). ESMO Open. 2022;7:100601. https:\/\/doi.org\/10.1016\/J.ESMOOP.2022.100601.","journal-title":"ESMO Open"},{"key":"4580_CR11","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1080\/01621459.1992.10476248","volume":"87","author":"RJ Gray","year":"1992","unstructured":"Gray RJ. Flexible methods for analyzing survival data using splines, with applications to breast cancer prognosis. J Am Stat Assoc. 1992;87:942\u201351. https:\/\/doi.org\/10.1080\/01621459.1992.10476248.","journal-title":"J Am Stat Assoc"},{"key":"4580_CR12","doi-asserted-by":"publisher","DOI":"10.2202\/1557-4679.1104","volume":"5","author":"US Govindarajulu","year":"2009","unstructured":"Govindarajulu US, Malloy EJ, Ganguli B, et al. The comparison of alternative smoothing methods for fitting non-linear exposure-response relationships with cox models in a simulation study. Int J Biostat. 2009;5:2. https:\/\/doi.org\/10.2202\/1557-4679.1104.","journal-title":"Int J Biostat"},{"key":"4580_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/J.BBRC.2020.03.064","volume":"526","author":"J Munir","year":"2020","unstructured":"Munir J, Van Ngu T, Na Ayudthaya PD, Ryu S. Downregulation of glypican-4 facilitates breast cancer progression by inducing cell migration and proliferation. Biochem Biophys Res Commun. 2020;526:91\u20137. https:\/\/doi.org\/10.1016\/J.BBRC.2020.03.064.","journal-title":"Biochem Biophys Res Commun"},{"key":"4580_CR14","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/S00432-021-03597-4","volume":"147","author":"PK Grillo","year":"2021","unstructured":"Grillo PK, Gy\u0151rffy B, G\u00f6tte M. Prognostic impact of the glypican family of heparan sulfate proteoglycans on the survival of breast cancer patients. J Cancer Res Clin Oncol. 2021;147:1937\u201355. https:\/\/doi.org\/10.1007\/S00432-021-03597-4.","journal-title":"J Cancer Res Clin Oncol"},{"key":"4580_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073945","volume":"25","author":"V Ch\u00e9rouvrier Hansson","year":"2024","unstructured":"Ch\u00e9rouvrier Hansson V, Cheng F, Georgolopoulos G, Mani K. Dichotomous effects of glypican-4 on cancer progression and its crosstalk with oncogenes. Int J Mol Sci. 2024;25:3945. https:\/\/doi.org\/10.3390\/ijms25073945.","journal-title":"Int J Mol Sci"},{"key":"4580_CR16","doi-asserted-by":"publisher","first-page":"6676","DOI":"10.1073\/pnas.0601752103","volume":"103","author":"S Gesta","year":"2006","unstructured":"Gesta S, Bl\u00fcher M, Yamamoto Y, et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci U S A. 2006;103:6676\u201381. https:\/\/doi.org\/10.1073\/pnas.0601752103.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4580_CR17","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/S10549-025-07678-7","volume":"211","author":"A Bellini","year":"2025","unstructured":"Bellini A, Keegan THM, Li Q, et al. The effect of body mass index on breast cancer stage and breast cancer specific survival. Breast Cancer Res Treat. 2025;211:649\u201356. https:\/\/doi.org\/10.1007\/S10549-025-07678-7.","journal-title":"Breast Cancer Res Treat"},{"key":"4580_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/CNCR.35799","volume":"131","author":"EV Mastrolonardo","year":"2025","unstructured":"Mastrolonardo EV, Llerena P, De Ravin E, et al. Improved survival with elevated BMI following immune checkpoint inhibition across various solid tumor cancer types. Cancer. 2025;131:e35799. https:\/\/doi.org\/10.1002\/CNCR.35799.","journal-title":"Cancer"},{"key":"4580_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/S41523-021-00241-9","volume":"7","author":"ND Modi","year":"2021","unstructured":"Modi ND, Tan JQE, Rowland A, et al. The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data. NPJ Breast Cancer. 2021;7:30. https:\/\/doi.org\/10.1038\/S41523-021-00241-9.","journal-title":"NPJ Breast Cancer"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04580-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04580-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:02:20Z","timestamp":1790661740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04580-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":19,"alternative-id":["4580"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04580-6","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"30 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The sponsor had no role in the design of the present translational analysis, data collection, data analysis, data interpretation, or manuscript preparation. Any potential relationships between the authors and pharmaceutical companies were unrelated to the present work and are not considered to have influenced the study. The authors declare no conflicts of interest relevant to this work.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study protocol was approved by an independent ethics committee (Ethik-Kommission bei der Landes\u00e4rztekammer Hessen), institutional review boards and the competent authority.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided written informed consent for trial participation and biomaterial collection.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}